|
Volumn 45, Issue 12, 2001, Pages 3591-3594
|
TEM-89 β-lactamase produced by a Proteus mirabilis clinical isolate: New complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
BETA LACTAMASE;
BETA LACTAMASE INHIBITOR;
CEFALORIDINE;
CEFALOTIN;
CEFOTAXIME;
CEFTAZIDIME;
CEFTRIAXONE;
CEFUROXIME;
CEPHALOSPORIN DERIVATIVE;
CLAVULANIC ACID;
PENICILLIN DERIVATIVE;
PENICILLIN G;
PIPERACILLIN;
SULBACTAM;
TAZOBACTAM;
TEM 89 BETA LACTAMASE;
TICARCILLIN;
UNCLASSIFIED DRUG;
AMINO ACID SUBSTITUTION;
ARTICLE;
DRUG HYDROLYSIS;
ENZYME ANALYSIS;
ENZYME SYNTHESIS;
MUTATION;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEUS MIRABILIS;
AMINO ACID SUBSTITUTION;
BETA-LACTAMASES;
CONJUGATION, GENETIC;
ESCHERICHIA COLI;
HUMANS;
ISOELECTRIC FOCUSING;
KINETICS;
MOLECULAR SEQUENCE DATA;
MUTATION;
PLASMIDS;
PROTEUS INFECTIONS;
PROTEUS MIRABILIS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
|
EID: 0035178731
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.45.12.3591-3594.2001 Document Type: Article |
Times cited : (29)
|
References (25)
|